Omeprazol Distri (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Distri, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage acid‑related disorders such as gastro‑esophageal reflux disease and peptic ulcer disease.

GNH USA supplies Omeprazol Distri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is indicated for several acid‑related conditions affecting the gastrointestinal tract. - Gastroesophageal reflux disease (GERD): relief of heartburn and esophageal irritation by reducing gastric acid exposure. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence by maintaining a higher gastric pH. - Erosive esophagitis: aids mucosal recovery and symptom control through acid suppression. - Helicobacter pylori eradication regimens: used in combination therapy to increase antibiotic effectiveness by lowering stomach acidity.

Omeprazole may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate pain often resolving without treatment. - Diarrhea: loose stools that may occur during the first weeks of therapy. - Nausea: transient feeling of queasiness or upset stomach. - Abdominal pain: discomfort or cramps in the stomach area. - Flatulence: increased gas production causing bloating.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis requiring immediate medical attention. - Low serum magnesium: hypomagnesemia that can cause muscle cramps, seizures, or cardiac arrhythmias. - Bone fracture risk: increased incidence of hip, wrist, or spine fractures with long‑term use. - Interstitial nephritis: inflammation of kidney tissue leading to impaired renal function.

When prescribing omeprazole, clinicians should consider several precautionary measures to ensure safe and effective use. - Assess renal function: dose adjustment may be required in patients with severe kidney impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia, especially in the elderly. - Evaluate need for long‑term use: limit duration to the shortest effective period to reduce risk of adverse effects. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. - Review concomitant medications: consider possible interactions that may affect drug efficacy or safety. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Omeprazole can alter the plasma concentrations of several co‑administered drugs, requiring attention to interaction potential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir and other protease inhibitors: markedly decreased antiviral absorption. - Ketoconazole and other azole antifungals: impaired absorption leading to therapeutic failure.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels may cause toxicity; monitor concentrations. - Methotrexate: reduced clearance can raise toxicity risk; check renal function. - Warfarin: variable effect on INR; monitor coagulation parameters. - Diazepam: increased sedation due to higher plasma levels; adjust dose if needed.